NCT02822495
Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies Not Available Not Available no_longer_available NCT04727242
CytoreductiveSurgery & HIPEC W/Gemcitabine+Chemotherapy W/Dacarbazine in Uterine Leiomyosarcoma treatment 2 recruiting NCT05227326
AOH1996 for the Treatment of Refractory Solid Tumors No drug interventions treatment 1 recruiting NCT05080790
Treatment with Dinutuximab Beta, Zoledronic Acid and Low-dose Interleukin (IL-2) in Patients with Leiomyosarcoma treatment 2 active_not_recruiting NCT06498648
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma treatment 1 / 2 not_yet_recruiting NCT06638931
Agnostic Therapy in Rare Solid Tumors No drug interventions treatment 2 recruiting NCT02180867
Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery treatment 2 / 3 active_not_recruiting NCT06088290
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma treatment 2 / 3 recruiting NCT06299163
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors No drug interventions treatment 1 recruiting NCT02249702
Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma treatment 2 completed NCT01956084
Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma No drug interventions treatment 1 active_not_recruiting NCT03526679
Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma treatment 1 / 2 unknown_status NCT05548179
Exploring Clinical Trial Experiences of People With Leiomyosarcoma No drug interventions Not Available Not Available not_yet_recruiting NCT06277154
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma treatment 2 not_yet_recruiting NCT04031677
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma No drug interventions treatment 3 recruiting NCT03241745
A Study of Nivolumab in Selected Uterine Cancer Patients treatment 2 completed NCT00815945
Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors treatment 2 completed NCT03899805
A Phase II Study of Eribulin and Pembrolizumab in Soft Tissue Sarcomas treatment 2 active_not_recruiting NCT06526897
Evaluation of Chest CT Versus Chest X-Ray for Lung Surveillance After Curative-Intent Resection of High-Risk Truncal-Extremity Soft Tissue Sarcoma No drug interventions diagnostic Not Available not_yet_recruiting NCT05116683
ATX-101 in Advanced Dedifferentiated Liposarcoma and Leiomyosarcoma treatment 2 terminated NCT05427461
Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2 No drug interventions other Not Available recruiting NCT05653388
Metastatic Leiomyosarcoma Biomarker Protocol No drug interventions Not Available Not Available recruiting NCT02584309
Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma treatment 2 completed NCT05204524
Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma treatment Not Available unknown_status NCT03989596
Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas No drug interventions treatment 2 unknown_status NCT02983539
Detection of Circulating Tumor Cells in Patients With Sarcomas No drug interventions Not Available Not Available unknown_status NCT00837148
Sorafenib and Dacarbazine in Soft Tissue Sarcoma treatment 2 completed NCT00668148
A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma treatment 2 completed NCT04214457
Development of a Predictive Model for Early Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas No drug interventions Not Available Not Available unknown_status NCT04055220
Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas treatment Not Available recruiting NCT06521060
The Role of Pre-Surgical Tru - Cut Biopsy in the Management of Atypical Myometrial Lesions No drug interventions Not Available Not Available not_yet_recruiting NCT00093080
Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED) treatment 2 completed NCT02247544
Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma treatment 2 completed NCT01418001
Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) treatment 1 / 2 terminated NCT05094804
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents treatment 1 / 2 recruiting NCT00062868
LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma No drug interventions treatment 1 completed NCT00400569
Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma treatment 2 completed NCT06528769
A Phase II Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma treatment 2 not_yet_recruiting NCT03761095
A Study of Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS) treatment 1 completed NCT00503295
Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung treatment 2 completed NCT03420014
Treatment of Metastatic Soft Tissue Sarcoma (STS) Patients (FIBROSARC USA) treatment 2 recruiting NCT05269355
A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS) treatment 2 / 3 active_not_recruiting NCT00856050
Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma treatment 2 completed NCT04242238
Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas treatment 1 active_not_recruiting NCT00282087
Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma treatment 2 completed NCT01426633
Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas treatment 1 completed NCT03959033
Patient Reported Outcome Measures (PROMs) With Trabectedin No drug interventions Not Available Not Available terminated NCT04099277
A Study of LY3435151 in Participants With Solid Tumors treatment 1 terminated NCT04535271
Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Leiomyosarcoma treatment 2 recruiting NCT04624178
A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma treatment 2 active_not_recruiting NCT02923778
Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery treatment 2 active_not_recruiting NCT03509207
Vorinostat (SAHA) in Uterine Sarcoma treatment 2 terminated NCT00887809
Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes treatment 2 completed NCT01447056
Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases No drug interventions treatment 1 completed NCT05116800
Phase 2 Study of 9-ING-41 With Chemotherapy in Sarcoma treatment 2 withdrawn NCT04420975
Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma treatment 1 active_not_recruiting NCT03651375
Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall No drug interventions treatment 2 unknown_status NCT03437070
Trabectedin, Doxorubicin and Olaratumab in Patients With Metastatic or Recurrent Leiomyosarcoma treatment 1 withdrawn NCT06308419
A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions treatment 1 recruiting NCT03016819
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) treatment 3 active_not_recruiting NCT02940041
Concordance Between Sonography Amd MRI for Presurgical Diagnosis of Uterine Mesenchymal Malignant Tumors No drug interventions Not Available Not Available terminated NCT04811196
A Study of Different Dosing Schedules of Selinexor in Sarcoma Patients treatment 1 active_not_recruiting NCT02275286
Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients treatment 1 / 2 recruiting NCT00356031
Bevacizumab and Radiation Therapy for Sarcomas treatment 2 completed NCT04906876
A Phase 2 Study of 9-ING-41Combined With Chemotherapy in Adolescents and Adults With Advanced Sarcomas treatment 2 withdrawn NCT00414076
Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma treatment 2 terminated NCT03718091
M6620 (VX-970) in Selected Solid Tumors treatment 2 completed NCT01442662
Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patient With Metastatic or Relapsed Uterine treatment 2 completed NCT04925089
Localized Leiomyosarcoma Biomarker Protocol No drug interventions Not Available Not Available recruiting NCT00060944
A Study to Assess Treatment With 2 Different Dosing Schedules of Trabectidin Administered to Patients With Advanced Cancer treatment 2 completed NCT04996004
A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma treatment 2 terminated NCT01793168
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford No drug interventions Not Available Not Available recruiting NCT03773510
Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin treatment 3 withdrawn NCT03851614
Basket Combination Study of Inhibitors of DNA Damage Response, Angiogenesis and Programmed Death Ligand 1 in Patients With Advanced Solid Tumors treatment 2 active_not_recruiting NCT04554914
A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases treatment 2 recruiting